Baruch S. Blumberg Institute to Host 15th Annual Regional Biotech Conference
Conference at PA Biotech Center to focus on reducing costs of drug development.
Doylestown, PA, October 03, 2015 --(PR.com)-- Date and time: Nov. 6, 2015, 8:30 a.m. to 1 p.m.
Location: Pennsylvania Biotechnology Center of Bucks County, 3805 Old Easton Road, Doylestown, PA 18902.
The Baruch S. Blumberg Institute, the research arm of the Hepatitis B Foundation, will host the 15th Annual Regional Biotech Conference, themed “Decreasing the Cost of Drug Development,” at its headquarters at the Pennsylvania Biotechnology Center in Doylestown, Pennsylvania. More than 100 of the area’s life science and biotechnology leaders will meet to learn more about reducing drug developments costs and share success stories and biotech opportunities. Registration is open and costs $75, which includes breakfast and lunch. This year’s Presenting Sponsor is Univest Bank and Trust Co.
Speakers and topics to be featured during the conference include:
Host:
Wayne Yetter, Founding CEO of Astra Merck, Inc. and CEO of Novartis Pharmaceuticals U.S.
Speakers:
Garry A. Neil, M.D., Chief Scientific Officer, Medgenics, Inc., Wayne, PA – “Rare and Orphan Diseases: The Key to Precision Medicine and Drug Development of the Future”
Ted Torphy, Ph.D., Chief Scientific Officer, BioMotiv, Cleveland, OH – “The Harrington Project: Improved Efficiencies in Drug Development”
Vivek Ramaswamy, J.D., Founder and Chief Executive Officer, Roivant Sciences Ltd., New York, NY – “A Combination Product for Hepatitis B: Keeping Development Costs Under Control”
For more information about the Regional Biotech Conference and sponsorship opportunities, please contact Bill Kinney at bill.kinney@blumberginstitute.org. To register, visit www.BlumbergInstitute.org.
About the Baruch S. Blumberg Institute
The Hepatitis B Foundation established an independent, nonprofit research institute in 2003 to conduct discovery research and nurture translational biotechnology in an environment conducive to interaction, collaboration and focus. Headquartered at the PA Biotechnology Center of Bucks County, the research center was renamed in 2013 to honor Baruch S. Blumberg, the man who won the Nobel Prize for his discovery of the hepatitis B virus. To learn more, visit www.blumberginstitute.org.
About the Pennsylvania Biotechnology Center
The Pennsylvania Biotechnology Center of Bucks County offers state-of-the-art laboratory and office space to nonprofit research companies and biotech companies. Created by a partnership between the Hepatitis B Foundation and Delaware Valley College, and managed by the Blumberg Institute, the Center was funded in part by the Commonwealth of Pennsylvania. The facility opened in 2006 in a formerly abandoned warehouse and has since grown to encompass 110,000 square feet on a 10-acre campus. To learn more, visit www.pabiotechbc.org.
Contact: Sarah Larson at sarah@furiarubel.com or 215-340-0480.
Location: Pennsylvania Biotechnology Center of Bucks County, 3805 Old Easton Road, Doylestown, PA 18902.
The Baruch S. Blumberg Institute, the research arm of the Hepatitis B Foundation, will host the 15th Annual Regional Biotech Conference, themed “Decreasing the Cost of Drug Development,” at its headquarters at the Pennsylvania Biotechnology Center in Doylestown, Pennsylvania. More than 100 of the area’s life science and biotechnology leaders will meet to learn more about reducing drug developments costs and share success stories and biotech opportunities. Registration is open and costs $75, which includes breakfast and lunch. This year’s Presenting Sponsor is Univest Bank and Trust Co.
Speakers and topics to be featured during the conference include:
Host:
Wayne Yetter, Founding CEO of Astra Merck, Inc. and CEO of Novartis Pharmaceuticals U.S.
Speakers:
Garry A. Neil, M.D., Chief Scientific Officer, Medgenics, Inc., Wayne, PA – “Rare and Orphan Diseases: The Key to Precision Medicine and Drug Development of the Future”
Ted Torphy, Ph.D., Chief Scientific Officer, BioMotiv, Cleveland, OH – “The Harrington Project: Improved Efficiencies in Drug Development”
Vivek Ramaswamy, J.D., Founder and Chief Executive Officer, Roivant Sciences Ltd., New York, NY – “A Combination Product for Hepatitis B: Keeping Development Costs Under Control”
For more information about the Regional Biotech Conference and sponsorship opportunities, please contact Bill Kinney at bill.kinney@blumberginstitute.org. To register, visit www.BlumbergInstitute.org.
About the Baruch S. Blumberg Institute
The Hepatitis B Foundation established an independent, nonprofit research institute in 2003 to conduct discovery research and nurture translational biotechnology in an environment conducive to interaction, collaboration and focus. Headquartered at the PA Biotechnology Center of Bucks County, the research center was renamed in 2013 to honor Baruch S. Blumberg, the man who won the Nobel Prize for his discovery of the hepatitis B virus. To learn more, visit www.blumberginstitute.org.
About the Pennsylvania Biotechnology Center
The Pennsylvania Biotechnology Center of Bucks County offers state-of-the-art laboratory and office space to nonprofit research companies and biotech companies. Created by a partnership between the Hepatitis B Foundation and Delaware Valley College, and managed by the Blumberg Institute, the Center was funded in part by the Commonwealth of Pennsylvania. The facility opened in 2006 in a formerly abandoned warehouse and has since grown to encompass 110,000 square feet on a 10-acre campus. To learn more, visit www.pabiotechbc.org.
Contact: Sarah Larson at sarah@furiarubel.com or 215-340-0480.
Contact
Hepatitis B Foundation
Rose Strong
215-340-0480
www.furiarubel.com
Rose Strong
215-340-0480
www.furiarubel.com
Contact
Categories